Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
Centro de investigación
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicacións en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (70)
2024
-
4CMenB journey to the 10-year anniversary and beyond
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype in Infants With Severe Respiratory Syncytial Virus Infection
Journal of Infectious Diseases, Vol. 229, pp. S100-S111
-
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 78, Núm. 6, pp. 1732-1744
-
Genome-wide Association Study of Susceptibility to Respiratory Syncytial Virus Hospitalization in Young Children <5 Years of age
Journal of Infectious Diseases, Vol. 230, Núm. 2, pp. e333-e341
-
Urgent Need to Understand and Prevent Gonococcal Infection: From the Laboratory to Real-World Context
The Journal of infectious diseases, Vol. 230, Núm. 4, pp. e758-e767
2023
-
Publisher Correction: The Value of Rotavirus Vaccination in Europe: A Call for Action (Infectious Diseases and Therapy, (2023), 12, 1, (9-29), 10.1007/s40121-022-00697-7)
Infectious Diseases and Therapy
-
Rule of Prevention: a potential framework to evaluate preventive interventions for rare diseases
Journal of Market Access and Health Policy, Vol. 11, Núm. 1
-
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12-23 Months of Age
The Journal of infectious diseases, Vol. 227, Núm. 11, pp. 1293-1302
-
Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain
Infectious Diseases and Therapy, Vol. 12, Núm. 1, pp. 157-175
-
The Value of Rotavirus Vaccination in Europe: A Call for Action
Infectious Diseases and Therapy
-
Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness
Expert review of vaccines, Vol. 22, Núm. 1, pp. 738-748
2022
-
Age-Specific Estimates of Respiratory Syncytial Virus-Associated Hospitalizations in 6 European Countries: A Time Series Analysis
Journal of Infectious Diseases, Vol. 226, pp. S29-S37
-
Clinical and Viral Factors Associated With Disease Severity and Subsequent Wheezing in Infants With Respiratory Syncytial Virus Infection
The Journal of infectious diseases, Vol. 226, Núm. 1, pp. S45-S54
-
Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations
Pathogens and Global Health, Vol. 116, Núm. 2, pp. 85-98
-
Global Disease Burden of Respiratory Syncytial Virus in Preterm Children in 2019: A Systematic Review and Individual Participant Data Meta-Analysis Protocol
Journal of Infectious Diseases, Vol. 226, pp. S135-S141
-
Incidence of herpes zoster and its complications in ≥ 50-year-old Spanish adults: A prospective cohort study
Vacunas, Vol. 23, Núm. 3, pp. 165-173
-
Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination
Open Forum Infectious Diseases, Vol. 9, Núm. 10
-
Patient Involvement in RSV Research: Towards Patients Setting the Research Agenda
Journal of Infectious Diseases, Vol. 226, pp. S130-S134
-
Range of invasive meningococcal disease sequelae and health economic application – a systematic and clinical review
BMC Public Health, Vol. 22, Núm. 1